Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Songlin Peng

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Scientific Reports|March 10, 2015
Src inhibitor reduces permeability without disturbing vascularization and prevents bone destruction in steroid-associated osteonecrotic lesions in rabbitsYi-Xin He, Jin Liu, Baosheng Guo, et al.
Heliyon|January 8, 2024
Identification of the transcriptome signatures and immune-inflammatory responses in postmenopausal osteoporosisPan Gao, Xiaoguang Pan, Shang Wang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 2, 2023
Magnesium Ascorbyl Phosphate Promotes Bone Formation Via CaMKII SignalingYongheng Xie, Zhiteng Bao, Zhenmin Wang, et al.
Nature Communications|August 26, 2018
Inhibition of osteoblastic Smurf1 promotes bone formation in mouse models of distinctive age-related osteoporosisChao Liang, Songlin Peng, Jie Li, et al.
Bone|November 20, 2013
Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formationBaosheng Guo, Baoting Zhang, Lizhen Zheng, et al.
Theranostics|November 18, 2020
Silencing of miR-138-5p sensitizes bone anabolic action to mechanical stimuliZhihao Chen, Fan Zhao, Chao Liang, et al.
International Journal of Biological Sciences|August 19, 2022
MiR-138-5p Targets MACF1 to Aggravate Aging-related Bone LossZhihao Chen, Ying Huai, Gaoyang Chen, et al.
Biomaterials|September 23, 2017
Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcomaChao Liang, Fangfei Li, Luyao Wang, et al.
Scientific Reports|January 11, 2017
Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancerJin Liu, Defang Li, Lei Dang, et al.
Nature Medicine|December 11, 2012
miR-214 targets ATF4 to inhibit bone formationXiaogang Wang, Baosheng Guo, Qi Li, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Scientific Reports|March 10, 2015
Src inhibitor reduces permeability without disturbing vascularization and prevents bone destruction in steroid-associated osteonecrotic lesions in rabbitsYi-Xin He, Jin Liu, Baosheng Guo, et al.
Heliyon|January 8, 2024
Identification of the transcriptome signatures and immune-inflammatory responses in postmenopausal osteoporosisPan Gao, Xiaoguang Pan, Shang Wang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 2, 2023
Magnesium Ascorbyl Phosphate Promotes Bone Formation Via CaMKII SignalingYongheng Xie, Zhiteng Bao, Zhenmin Wang, et al.
Nature Communications|August 26, 2018
Inhibition of osteoblastic Smurf1 promotes bone formation in mouse models of distinctive age-related osteoporosisChao Liang, Songlin Peng, Jie Li, et al.
Bone|November 20, 2013
Therapeutic RNA interference targeting CKIP-1 with a cross-species sequence to stimulate bone formationBaosheng Guo, Baoting Zhang, Lizhen Zheng, et al.
Theranostics|November 18, 2020
Silencing of miR-138-5p sensitizes bone anabolic action to mechanical stimuliZhihao Chen, Fan Zhao, Chao Liang, et al.
International Journal of Biological Sciences|August 19, 2022
MiR-138-5p Targets MACF1 to Aggravate Aging-related Bone LossZhihao Chen, Ying Huai, Gaoyang Chen, et al.
Biomaterials|September 23, 2017
Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcomaChao Liang, Fangfei Li, Luyao Wang, et al.
Scientific Reports|January 11, 2017
Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancerJin Liu, Defang Li, Lei Dang, et al.
Nature Medicine|December 11, 2012
miR-214 targets ATF4 to inhibit bone formationXiaogang Wang, Baosheng Guo, Qi Li, et al.
Pageof 10